Recent Discussions🔔 Update on access to Zoladex treatment We heard your concerns about AstraZeneca's decision to discontinue Zoladex 3.6mg from 1 November 2026 - and we went to work on your behalf. After coordinating advocacy with clinicians, consum...Aligning PBS Policy with Contemporary HER2-Positive Metastatic Breast Cancer Care I am concerned about a structural problem in how HER2-positive metastatic breast cancer is managed under current PBS rules. Patients who achieve an excellent response to T-DM1 or T-DXd cannot step d...📢 Capivasertib (Truqap) to be listed on the PBS! The Australian Government has announced that as of 1 October capivasertib (Truqap) will be listed on the Pharmacetucial Benefits Scheme (PBS), providing another vital option for Australians with ...
Tagsmedication1 Topicmetastatic breast cancer1 TopicPBS1 Topictreatment1 Topiczoladex1 Topicadvocacy1 Topicnews1 Topic
